Skip to main content
. Author manuscript; available in PMC: 2019 Sep 1.
Published in final edited form as: Psychopharmacology (Berl). 2018 Jul 7;235(9):2713–2723. doi: 10.1007/s00213-018-4966-9

Table 1:

Clinical and demographic characteristics

All Participants Participants with Stress Events Participants with Drug Use Events
N 182 158 149
Sex
 males 135 (74.2%) 113 (71.5%) 107 (71.8%)
Age mean (SD) years 41.9 (9.6) 42.4 (9.7) 42.0 (9.6)
Race
 African American 118 (64.8%) 102 (64.6%) 95 (63.8%)
 White 62 (34.0%) 52 (32.9%) 52 (34.9%)
Education mean (SD) years 12.1 (1.5) 12.1 (1.6) 12.1 (1.5)
Marital Status
 Married 24 (13.3%) 23 (14.6%) 20 (13.5%)
 Never married 111 (60.8%) 95 (59.9%) 94 (62.8%)
 Separated/divorced/widowed 47 (26.0%) 40 (25.5%) 35 (23.6%)
Employment Status
 Full time 84 (46.4%) 70 (44.0%) 69 (46.0%)
 Part time 41 (22.6%) 36 (22.9%) 31 (21.0%)
 Unemployed 46 (25.4%) 42 (26.8%) 39 (26.4%)
 Retired/disability/controlled 10 (5.5%) 10 (6.4%) 10 (6.8%)
Drug-Use History
Days used in last 30
  Heroin mean (SD) 19.3 (11.9) 19.1 (11.9) 20.8 (11.0)
  Other opioid mean (SD) 8.1 (10.3) 8.0 (10.3) 7.2 (9.3)
  Cocaine mean (SD) 4.5 (8.5) 4.6 (8.5) 5.3 (9.1)
Years Using
  Heroin mean (SD) 14.5 (10.2) 14.5 (10.5) 14.7 (9.9)
  Other opioid mean (SD) 1.4 (2.6) 1.5 (2.8) 1.4 (2.6)
  Cocaine mean (SD) 6.0 (8.0) 6.2 (8.1) 6.5 (8.2)
Opioid agonist treatment*
 Methadone 107 (58.8%) 91 (57.6%) 88 (59.1%)
 Buprenorphine/naloxone 75 (41.2%) 67 (42.4%) 61 (40.9%)
Urine drug screen results*
 Opioids mean % negative (SD) 61.8% (38.2) 61.0% (36.7) 53.6% (34.5)
 Cocaine mean % negative (SD) 66.2% (39.6) 65.2% (39.8) 58.7% (34.5)
 Cannabis mean % negative (SD) 85.8% (29.3) 85.9% (29.0) 83.4% (29.9)
*

Data collected during the study; all other measures were collected during screening on the Addiction Severity Index (McLellan et al., 1985).